The DOI matches its Crossref record; 73 of the 73 references it cites were found in a registry or an index.
Structure of the Nanobody-Stabilized Active State of the Kappa Opioid Receptor
Open accessAbstract
Summary The kappa-opioid receptor (KOP) mediates the actions of opioids with hallucinogenic, dysphoric and analgesic activities. The design of KOP analgesics devoid of hallucinatory and dysphoric effects has been hindered by an incomplete structural and mechanistic understanding of KOP agonist actions. Here we provide a crystal structure of the human KOP in complex with the potent epoxymorphinan opioid agonist MP1104 and an active state stabilizing nanobody. Comparisons between inactive and active state opioid receptor structures reveal substantial conformational changes in the binding pocket, intracellular and extracellular regions. Extensive structural analysis and experimental validation illuminate key residues that propagate larger scale structural rearrangements and transducer binding that, collectively, elucidate the structural determinants of KOP pharmacology, function, and biased signaling. These molecular insights promise to accelerate the structure-guided design of safer and more effective kappa-opioid receptor therapeutics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
PROCHECK: a program to check the stereochemical quality of protein structures
Laskowski, R. A., MacArthur, M. W., Moss, D. S., & Thornton, J. M. (1993) · Journal of Applied Crystallography · doi:10.1107/s0021889892009944 · Cited by 24,581
PHENIX : a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444909052925 · Cited by 23,716
Phaser crystallographic software
McCoy, A. J., Grosse-Kunstleve, R. W., Adams, P. D., Winn, M. D., Storoni, L. C., & Read, R. J. (2007) · Journal of Applied Crystallography · doi:10.1107/s0021889807021206 · Cited by 20,612
GROMACS: Fast, flexible, and free
Van Der Spoel, D., Lindahl, E., Hess, B., Groenhof, G., Mark, A. E., & Berendsen, H. J. C. (2005) · Journal of Computational Chemistry · doi:10.1002/jcc.20291 · Cited by 19,182
Refinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,742
PHENIX: a comprehensive Python-based system for macromolecular structure solution
Adams, P. D., Afonine, P. V., Bunkóczi, G., Chen, V. B., Davis, I. W., Echols, N., Headd, J. J., Hung, L.-W., Kapral, G. J., Grosse-Kunstleve, R. W., et al. (2012) · International Tables for Crystallography · doi:10.1107/97809553602060000865 · Cited by 7,334
Best, R. B., Zhu, X., Shim, J., Lopes, P. E. M., Mittal, J., Feig, M., & MacKerell, A. D. (2012) · Journal of Chemical Theory and Computation · doi:10.1021/ct300400x · Cited by 4,532
Lee, J., Cheng, X., Swails, J. M., Yeom, M. S., Eastman, P. K., Lemkul, J. A., Wei, S., Buckner, J., Jeong, J. C., Qi, Y., et al. (2016) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5b00935 · Cited by 4,171
Crystal structure of the β2 adrenergic receptor–Gs protein complex
Rasmussen, S. G. F., DeVree, B. T., Zou, Y., Kruse, A. C., Chung, K. Y., Kobilka, T. S., Thian, F. S., Chae, P. S., Pardon, E., Calinski, D., et al. (2011) · Nature · doi:10.1038/nature10361 · Cited by 3,009
Self-citationMartin, W. R., Eades, C. G., Thompson, J. A., Huppler, R. E., & Gilbert, P. E. (1976) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30536-7 · Cited by 2,992
Minor, W., Cymborowski, M., Otwinowski, Z., & Chruszcz, M. (2006) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444906019949 · Cited by 2,099
Abagyan, R., Totrov, M., & Kuznetsov, D. (1994) · Journal of Computational Chemistry · doi:10.1002/jcc.540150503 · Cited by 1,699
Structure of a nanobody-stabilized active state of the β2 adrenoceptor
Rasmussen, S. G. F., Choi, H.-J., Fung, J. J., Pardon, E., Casarosa, P., Chae, P. S., DeVree, B. T., Rosenbaum, D. M., Thian, F. S., Kobilka, T. S., et al. (2011) · Nature · doi:10.1038/nature09648 · Cited by 1,680
Self-citationMolecular signatures of G-protein-coupled receptors
Venkatakrishnan, A. J., Deupi, X., Lebon, G., Tate, C. G., Schertler, G. F., & Babu, M. M. (2013) · Nature · doi:10.1038/nature11896 · Cited by 1,497
Crystal structure of the µ-opioid receptor bound to a morphinan antagonist
Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Mathiesen, J. M., Sunahara, R. K., Pardo, L., Weis, W. I., Kobilka, B. K., & Granier, S. (2012) · Nature · doi:10.1038/nature10954 · Cited by 1,356
Improved prediction of protein side‐chain conformations with SCWRL4
Krivov, G. G., Shapovalov, M. V., & Dunbrack, R. L. (2009) · Proteins: Structure, Function, and Bioinformatics · doi:10.1002/prot.22488 · Cited by 1,301
Samama, P., Cotecchia, S., Costa, T., & Lefkowitz, R. J. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53442-6 · Cited by 1,257
OPM: Orientations of Proteins in Membranes database
Lomize, M. A., Lomize, A. L., Pogozheva, I. D., & Mosberg, H. I. (2006) · Bioinformatics · doi:10.1093/bioinformatics/btk023 · Cited by 1,173
Dynorphin Is a Specific Endogenous Ligand of the κ Opioid Receptor
Chavkin, C., James, I. F., & Goldstein, A. (1982) · Science · doi:10.1126/science.6120570 · Cited by 1,168
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
Urban, J. D., Clarke, W. P., von Zastrow, M., Nichols, D. E., Kobilka, B., Weinstein, H., Javitch, J. A., Roth, B. L., Christopoulos, A., Sexton, P. M., et al. (2007) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.104463 · Cited by 1,116
Self-citationCrystal structure of opsin in its G-protein-interacting conformation
Scheerer, P., Park, J. H., Hildebrand, P. W., Kim, Y. J., Krauß, N., Choe, H.-W., Hofmann, K. P., & Ernst, O. P. (2008) · Nature · doi:10.1038/nature07330 · Cited by 1,059
Structure-Function of the G Protein–Coupled Receptor Superfamily
Katritch, V., Cherezov, V., & Stevens, R. C. (2013) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-032112-135923 · Cited by 1,054
Self-citationOperational models of pharmacological agonism
Black, J. W., & Leff, P. (1983) · Proceedings of the Royal Society of London. Series B. Biological Sciences · doi:10.1098/rspb.1983.0093 · Cited by 951
Structure-based discovery of opioid analgesics with reduced side effects
Manglik, A., Lin, H., Aryal, D. K., McCorvy, J. D., Dengler, D., Corder, G., Levit, A., Kling, R. C., Bernat, V., Hübner, H., et al. (2016) · Nature · doi:10.1038/nature19112 · Cited by 944
Self-citationActivation and allosteric modulation of a muscarinic acetylcholine receptor
Kruse, A. C., Ring, A. M., Manglik, A., Hu, J., Hu, K., Eitel, K., Hübner, H., Pardon, E., Valant, C., Sexton, P. M., et al. (2013) · Nature · doi:10.1038/nature12735 · Cited by 893
Self-citationStructural insights into µ-opioid receptor activation
Huang, W., Manglik, A., Venkatakrishnan, A. J., Laeremans, T., Feinberg, E. N., Sanborn, A. L., Kato, H. E., Livingston, K. E., Thorsen, T. S., Kling, R. C., et al. (2015) · Nature · doi:10.1038/nature14886 · Cited by 885
Self-citationStructure of the human κ-opioid receptor in complex with JDTic
Wu, H., Wacker, D., Mileni, M., Katritch, V., Han, G. W., Vardy, E., Liu, W., Thompson, A. A., Huang, X.-P., Carroll, F. I., et al. (2012) · Nature · doi:10.1038/nature10939 · Cited by 879
Self-citationPsychotomimesis Mediated by κ Opiate Receptors
Pfeiffer, A., Brantl, V., Herz, A., & Emrich, H. M. (1986) · Science · doi:10.1126/science.3016896 · Cited by 857
Crystal structure of rhodopsin bound to arrestin by femtosecond X-ray laser
Kang, Y., Zhou, X. E., Gao, X., He, Y., Liu, W., Ishchenko, A., Barty, A., White, T. A., Yefanov, O., Han, G. W., et al. (2015) · Nature · doi:10.1038/nature14656 · Cited by 807
Self-citationA general protocol for the generation of Nanobodies for structural biology
Pardon, E., Laeremans, T., Triest, S., Rasmussen, S. G. F., Wohlkönig, A., Ruf, A., Muyldermans, S., Hol, W. G. J., Kobilka, B. K., & Steyaert, J. (2014) · Nature Protocols · doi:10.1038/nprot.2014.039 · Cited by 790
Self-citationSalvinorin A: A potent naturally occurring nonnitrogenous κ opioid selective agonist
Roth, B. L., Baner, K., Westkaemper, R., Siebert, D., Rice, K. C., Steinberg, S., Ernsberger, P., & Rothman, R. B. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.182234399 · Cited by 784
Self-citationPRESTO-Tango as an open-source resource for interrogation of the druggable human GPCRome
Kroeze, W. K., Sassano, M. F., Huang, X.-P., Lansu, K., McCorvy, J. D., Giguère, P. M., Sciaky, N., & Roth, B. L. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.3014 · Cited by 755
Self-citationSignalling bias in new drug discovery: detection, quantification and therapeutic impact
Kenakin, T., & Christopoulos, A. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3954 · Cited by 740
Crystallizing membrane proteins using lipidic mesophases
Caffrey, M., & Cherezov, V. (2009) · Nature Protocols · doi:10.1038/nprot.2009.31 · Cited by 670
Self-citationStructure of the δ-opioid receptor bound to naltrindole
Granier, S., Manglik, A., Kruse, A. C., Kobilka, T. S., Thian, F. S., Weis, W. I., & Kobilka, B. K. (2012) · Nature · doi:10.1038/nature11111 · Cited by 667
Structural Features for Functional Selectivity at Serotonin Receptors
Wacker, D., Wang, C., Katritch, V., Han, G. W., Huang, X.-P., Vardy, E., McCorvy, J. D., Jiang, Y., Chu, M., Siu, F. Y., et al. (2013) · Science · doi:10.1126/science.1232808 · Cited by 664
Self-citationCHARMM-GUI ligand reader and modeler for CHARMM force field generation of small molecules
Kim, S., Lee, J., Jo, S., Brooks, C. L., Lee, H. S., & Im, W. (2017) · Journal of Computational Chemistry · doi:10.1002/jcc.24829 · Cited by 642
Smart, O. S., Womack, T. O., Flensburg, C., Keller, P., Paciorek, W., Sharff, A., Vonrhein, C., & Bricogne, G. (2012) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444911056058 · Cited by 612
How Ligands Illuminate GPCR Molecular Pharmacology
Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560 · cited 3×
“Accordingly, even small modifications to identical scaffolds can subtly affect a compound’s binding mode and, thereby, its potency and/or efficacy, as observed for other GPCR ligands (Wacker et al., 2017b).”
Self-citationOpiate Agonists and Antagonists Discriminated by Receptor Binding in Brain
Pert, C. B., Pasternak, G., & Snyder, S. H. (1973) · Science · doi:10.1126/science.182.4119.1359 · Cited by 546
Self-citationThe dynorphin/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors
Bruchas, M. R., Land, B. B., & Chavkin, C. (2010) · Brain Research · doi:10.1016/j.brainres.2009.08.062 · Cited by 544
Allosteric sodium in class A GPCR signaling
Katritch, V., Fenalti, G., Abola, E. E., Roth, B. L., Cherezov, V., & Stevens, R. C. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.03.002 · Cited by 511
Self-citationMolecular control of δ-opioid receptor signalling
Fenalti, G., Giguere, P. M., Katritch, V., Huang, X.-P., Thompson, A. A., Cherezov, V., Roth, B. L., & Stevens, R. C. (2014) · Nature · doi:10.1038/nature12944 · Cited by 497
Self-citationA Simple Method for Quantifying Functional Selectivity and Agonist Bias
Kenakin, T., Watson, C., Muniz-Medina, V., Christopoulos, A., & Novick, S. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn200111m · Cited by 484
Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Thompson, A. A., Liu, W., Chun, E., Katritch, V., Wu, H., Vardy, E., Huang, X.-P., Trapella, C., Guerrini, R., Calo, G., et al. (2012) · Nature · doi:10.1038/nature11085 · Cited by 477
Self-citationFusion Partner Toolchest for the Stabilization and Crystallization of G Protein-Coupled Receptors
Chun, E., Thompson, A. A., Liu, W., Roth, C. B., Griffith, M. T., Katritch, V., Kunken, J., Xu, F., Cherezov, V., Hanson, M. A., et al. (2012) · Structure · doi:10.1016/j.str.2012.04.010 · Cited by 461
Self-citationCrystal Structure of an LSD-Bound Human Serotonin Receptor
Wacker, D., Wang, S., McCorvy, J. D., Betz, R. M., Venkatakrishnan, A. J., Levit, A., Lansu, K., Schools, Z. L., Che, T., Nichols, D. E., et al. (2017) · Cell · doi:10.1016/j.cell.2016.12.033 · Cited by 457
Self-citationSerial Femtosecond Crystallography of G Protein–Coupled Receptors
Liu, W., Wacker, D., Gati, C., Han, G. W., James, D., Wang, D., Nelson, G., Weierstall, U., Katritch, V., Barty, A., et al. (2013) · Science · doi:10.1126/science.1244142 · Cited by 455
Self-citationStructure of the adenosine A2A receptor bound to an engineered G protein
Carpenter, B., Nehmé, R., Warne, T., Leslie, A. G. W., & Tate, C. G. (2016) · Nature · doi:10.1038/nature18966 · Cited by 435
β2 Adrenergic Receptor Activation
Shi, L., Liapakis, G., Xu, R., Guarnieri, F., Ballesteros, J. A., & Javitch, J. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m206801200 · Cited by 422
A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior
Vardy, E., Robinson, J. E., Li, C., Olsen, R. H. J., DiBerto, J. F., Giguere, P. M., Sassano, F. M., Huang, X.-P., Zhu, H., Urban, D. J., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.03.065 · Cited by 380
Self-citationD4dopamine receptor high-resolution structures enable the discovery of selective agonists
Wang, S., Wacker, D., Levit, A., Che, T., Betz, R. M., McCorvy, J. D., Venkatakrishnan, A. J., Huang, X.-P., Dror, R. O., Shoichet, B. K., et al. (2017) · Science · doi:10.1126/science.aan5468 · Cited by 261
Self-citationHydrophobicity: is LogPo/w more than the sum of its parts?
Eugene Kellogg, G., & Abraham, D. J. (2000) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(00)00167-7 · Cited by 244
Brust, T. F., Morgenweck, J., Kim, S. A., Rose, J. H., Locke, J. L., Schmid, C. L., Zhou, L., Stahl, E. L., Cameron, M. D., Scarry, S. M., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aai8441 · Cited by 240
A nontoxic pain killer designed by modeling of pathological receptor conformations
Spahn, V., Del Vecchio, G., Labuz, D., Rodriguez-Gaztelumendi, A., Massaly, N., Temp, J., Durmaz, V., Sabri, P., Reidelbach, M., Machelska, H., et al. (2017) · Science · doi:10.1126/science.aai8636 · Cited by 229
White, K. L., Robinson, J. E., Zhu, H., DiBerto, J. F., Polepally, P. R., Zjawiony, J. K., Nichols, D. E., Malanga, C. J., & Roth, B. L. (2015) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.216820 · Cited by 203
Self-citationStructural basis for bifunctional peptide recognition at human δ-opioid receptor
Fenalti, G., Zatsepin, N. A., Betti, C., Giguere, P., Han, G. W., Ishchenko, A., Liu, W., Guillemyn, K., Zhang, H., James, D., et al. (2015) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2965 · Cited by 180
Self-citationMajumdar, S., Grinnell, S. G., Rouzic, V. L., Burgman, M., Polikar, L., Ansonoff, M. A., Pintar, J. E., Pan, Y., & Pasternak, G. W. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1115231108 · Cited by 156
Self-citationHolst, B., Nygaard, R., Valentin-Hansen, L., Bach, A., Engelstoft, M. S., Petersen, P. S., Frimurer, T. M., & Schwartz, T. W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.064725 · Cited by 150
Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A
Cunningham, C. W., Rothman, R. B., & Prisinzano, T. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003244 · Cited by 113
NMR structure and dynamics of the agonist dynorphin peptide bound to the human kappa opioid receptor
O’Connor, C., White, K. L., Doncescu, N., Didenko, T., Roth, B. L., Czaplicki, G., Stevens, R. C., Wüthrich, K., & Milon, A. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1510117112 · Cited by 99
Self-citationYan, F., Bikbulatov, R. V., Mocanu, V., Dicheva, N. N., Parker, C. E., Wetsel, W. C., Mosier, P. D., Westkaemper, R. B., Allen, J., Zjawiony, J. K., et al. (2009) · Biochemistry · doi:10.1021/bi900605n · Cited by 84
Self-citationSpetea, M., Eans, S. O., Ganno, M. L., Lantero, A., Mairegger, M., Toll, L., Schmidhammer, H., & McLaughlin, J. P. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13854 · Cited by 81
Chu, R., Takei, J., Knowlton, J. R., Andrykovitch, M., Pei, W., Kajava, A. V., Steinbach, P. J., Ji, X., & Bai, Y. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00884-7 · Cited by 80
New Technologies for Elucidating Opioid Receptor Function
Bruchas, M. R., & Roth, B. L. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.01.001 · Cited by 76
Self-citationChemotype-selective Modes of Action of κ-Opioid Receptor Agonists
Vardy, E., Mosier, P. D., Frankowski, K. J., Wu, H., Katritch, V., Westkaemper, R. B., Aubé, J., Stevens, R. C., & Roth, B. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.515668 · Cited by 71
Self-citationAntagonists of the kappa opioid receptor
Urbano, M., Guerrero, M. A., Rosen, H., & Roberts, E. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.03.040 · Cited by 69
Zheng, Z., Huang, X., Mangano, T. J., Zou, R., Chen, X., Zaidi, S. A., Roth, B. L., Stevens, R. C., & Katritch, V. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00109 · Cited by 62
Self-citationVáradi, A., Marrone, G. F., Eans, S. O., Ganno, M. L., Subrath, J. J., Rouzic, V. L., Hunkele, A., Pasternak, G. W., McLaughlin, J. P., & Majumdar, S. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00153 · Cited by 60
Self-citationMajumdar, S., Subrath, J. J., Rouzic, V. L., Polikar, L., Burgman, M., Nagakura, K., Ocampo, J., Haselton, N., Pasternak, A. R., Grinnell, S. G., et al. (2012) · Journal of Medicinal Chemistry · doi:10.1021/jm300305c · Cited by 53
Self-citationLarson, D. L., Jones, R. M., Hjorth, S. A., Schwartz, T. W., & Portoghese, P. S. (2000) · Journal of Medicinal Chemistry · doi:10.1021/jm000059g · Cited by 48
Valentin-Hansen, L., Holst, B., Frimurer, T. M., & Schwartz, T. W. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.395137 · Cited by 38
Cited by
Mechanisms of signalling and biased agonism in G protein-coupled receptors
Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M., & Sexton, P. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0049-3 · Cited by 724
Structure of the µ-opioid receptor–Gi protein complex
Koehl, A., Hu, H., Maeda, S., Zhang, Y., Qu, Q., Paggi, J. M., Latorraca, N. R., Hilger, D., Dawson, R., Matile, H., et al. (2018) · Nature · doi:10.1038/s41586-018-0219-7 · Cited by 658
Common activation mechanism of class A GPCRs
Zhou, Q., Yang, D., Wu, M., Guo, Y., Guo, W., Zhong, L., Cai, X., Dai, A., Jang, W., Shakhnovich, E. I., et al. (2019) · eLife · doi:10.7554/elife.50279 · Cited by 632
Self-citationStructure of a Hallucinogen-Activated Gq-Coupled 5-HT2A Serotonin Receptor
Kim, K., Che, T., Panova, O., DiBerto, J. F., Lyu, J., Krumm, B. E., Wacker, D., Robertson, M. J., Seven, A. B., Nichols, D. E., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.024 · Cited by 481
Self-citationThe Art and Science of Molecular Docking
Paggi, J. M., Pandit, A., & Dror, R. O. (2024) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-030222-120000 · Cited by 459
Metadata
- Authors
- Che, T., Majumdar, S., Zaidi, S. A., Ondachi, P., McCorvy, J. D., Wang, S., Mosier, P. D., Uprety, R., Vardy, E., Krumm, B. E., Han, G. W., Lee, M.-Y., Pardon, E., Steyaert, J., Huang, X.-P., Strachan, R. T., Tribo, A. R., Pasternak, G. W., Carroll, F. I., Stevens, R. C., Cherezov, V., Katritch, V., Wacker, D., & Roth, B. L.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2018-01
- Volume
- 172
- Issue
- 1-2
- Pages
- 55-67.e15
- ISSN
- 0092-8674 (ISSN-L)
- OpenAlex
- W2781483269
- Cited by
- 365
- References
- 73
- FWCI
- 17.26
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.